ID   TXK_HUMAN               Reviewed;         527 AA.
AC   P42681; Q14220;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   15-MAR-2017, entry version 168.
DE   RecName: Full=Tyrosine-protein kinase TXK;
DE            EC=2.7.10.2;
DE   AltName: Full=Protein-tyrosine kinase 4;
DE   AltName: Full=Resting lymphocyte kinase;
GN   Name=TXK; Synonyms=PTK4, RLK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT HIS-45, AND TISSUE SPECIFICITY.
RC   TISSUE=Blood;
RX   PubMed=7951233; DOI=10.1093/hmg/3.6.897;
RA   Haire R.N., Ohta Y., Lewis J.E., Fu S.M., Kroisel P.M., Litman G.W.;
RT   "TXK, a novel human tyrosine kinase expressed in T cells shares
RT   sequence identity with Tec family kinases and maps to 4p12.";
RL   Hum. Mol. Genet. 3:897-901(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=8632917;
RA   Ohta Y., Haire R.N., Amemiya C.T., Litman R.T., Trager T., Riess O.,
RA   Litman G.W.;
RT   "Human Txk: genomic organization, structure and contiguous physical
RT   linkage with the Tec gene.";
RL   Oncogene 12:937-942(1996).
RN   [3]
RP   FUNCTION IN PHOSPHORYLATION OF CTLA4, AND MUTAGENESIS OF LYS-299.
RX   PubMed=9813138; DOI=10.1006/bbrc.1998.9559;
RA   Schneider H., Schwartzberg P.L., Rudd C.E.;
RT   "Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and
RT   regulates PI 3-kinase binding to T-cell antigen CTLA-4.";
RL   Biochem. Biophys. Res. Commun. 252:14-19(1998).
RN   [4]
RP   TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=10523612; DOI=10.1084/jem.190.8.1147;
RA   Kashiwakura J., Suzuki N., Nagafuchi H., Takeno M., Takeba Y.,
RA   Shimoyama Y., Sakane T.;
RT   "Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in
RT   T helper type 1 cells and regulates interferon gamma production in
RT   human T lymphocytes.";
RL   J. Exp. Med. 190:1147-1154(1999).
RN   [5]
RP   FUNCTION IN PHOSPHORYLATION OF PLCG1.
RX   PubMed=11564877; DOI=10.1128/MCB.21.20.6939-6950.2001;
RA   Veri M.C., DeBell K.E., Seminario M.C., DiBaldassarre A., Reischl I.,
RA   Rawat R., Graham L., Noviello C., Rellahan B.L., Miscia S.,
RA   Wange R.L., Bonvini E.;
RT   "Membrane raft-dependent regulation of phospholipase Cgamma-1
RT   activation in T lymphocytes.";
RL   Mol. Cell. Biol. 21:6939-6950(2001).
RN   [6]
RP   AUTOPHOSPHORYLATION, PHOSPHORYLATION AT TYR-91 AND TYR-420, ENZYME
RP   REGULATION, AND MUTAGENESIS OF TYR-91.
RX   PubMed=12081135; DOI=10.1248/bpb.25.718;
RA   Kashiwakura J., Suzuki N., Takeno M., Itoh S., Oku T., Sakane T.,
RA   Nakajin S., Toyoshima S.;
RT   "Evidence of autophosphorylation in Txk: Y91 is an autophosphorylation
RT   site.";
RL   Biol. Pharm. Bull. 25:718-721(2002).
RN   [7]
RP   DNA-BINDING, AND FUNCTION.
RX   PubMed=11859127; DOI=10.4049/jimmunol.168.5.2365;
RA   Takeba Y., Nagafuchi H., Takeno M., Kashiwakura J., Suzuki N.;
RT   "Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a
RT   Th1 cell-specific transcription factor and regulates IFN-gamma gene
RT   transcription.";
RL   J. Immunol. 168:2365-2370(2002).
RN   [8]
RP   INTERACTION WITH PARP1 AND EEF1A1, FUNCTION IN PHOSPHORYLATION OF
RP   PARP1 AND EEF1A1, SUBCELLULAR LOCATION, AND FUNCTION AS A
RP   TRANSCRIPTION FACTOR.
RX   PubMed=17177976; DOI=10.1111/j.1365-2249.2006.03249.x;
RA   Maruyama T., Nara K., Yoshikawa H., Suzuki N.;
RT   "Txk, a member of the non-receptor tyrosine kinase of the Tec family,
RT   forms a complex with poly(ADP-ribose) polymerase 1 and elongation
RT   factor 1alpha and regulates interferon-gamma gene transcription in Th1
RT   cells.";
RL   Clin. Exp. Immunol. 147:164-175(2007).
RN   [9]
RP   REVIEW ON FUNCTION.
RX   PubMed=19290923; DOI=10.1111/j.1600-065X.2008.00757.x;
RA   Readinger J.A., Mueller K.L., Venegas A.M., Horai R.,
RA   Schwartzberg P.L.;
RT   "Tec kinases regulate T-lymphocyte development and function: new
RT   insights into the roles of Itk and Rlk/Txk.";
RL   Immunol. Rev. 228:93-114(2009).
RN   [10]
RP   STRUCTURE BY NMR OF 140-251.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SH2 domain of human tyrosine-protein kinase
RT   TXK.";
RL   Submitted (OCT-2006) to the PDB data bank.
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-45; CYS-63 AND GLN-336.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor tyrosine kinase that plays a redundant role
CC       with ITK in regulation of the adaptive immune response. Regulates
CC       the development, function and differentiation of conventional T-
CC       cells and nonconventional NKT-cells. When antigen presenting cells
CC       (APC) activate T-cell receptor (TCR), a series of phosphorylation
CC       lead to the recruitment of TXK to the cell membrane, where it is
CC       phosphorylated at Tyr-420. Phosphorylation leads to TXK full
CC       activation. Contributes also to signaling from many receptors and
CC       participates in multiple downstream pathways, including regulation
CC       of the actin cytoskeleton. Like ITK, can phosphorylate PLCG1,
CC       leading to its localization in lipid rafts and activation,
CC       followed by subsequent cleavage of its substrates. In turn, the
CC       endoplasmic reticulum releases calcium in the cytoplasm and the
CC       nuclear activator of activated T-cells (NFAT) translocates into
CC       the nucleus to perform its transcriptional duty. With PARP1 and
CC       EEF1A1, TXK forms a complex that acts as a T-helper 1 (Th1) cell-
CC       specific transcription factor and binds the promoter of IFNG to
CC       directly regulate its transcription, and is thus involved
CC       importantly in Th1 cytokine production. Phosphorylates both PARP1
CC       and EEF1A1. Phosphorylates also key sites in LCP2 leading to the
CC       up-regulation of Th1 preferred cytokine IL-2. Phosphorylates 'Tyr-
CC       201' of CTLA4 which leads to the association of PI-3 kinase with
CC       the CTLA4 receptor. {ECO:0000269|PubMed:10523612,
CC       ECO:0000269|PubMed:11564877, ECO:0000269|PubMed:11859127,
CC       ECO:0000269|PubMed:17177976, ECO:0000269|PubMed:9813138}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- ENZYME REGULATION: Activated by phosphorylation by FYN.
CC       {ECO:0000269|PubMed:12081135}.
CC   -!- SUBUNIT: Interacts with PARP1 and EEF1A1. Interacts with SH2D2A
CC       (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P10721:KIT; NbExp=3; IntAct=EBI-7877438, EBI-1379503;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17177976}.
CC       Nucleus {ECO:0000269|PubMed:17177976}. Cell membrane
CC       {ECO:0000269|PubMed:17177976}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17177976}. Note=Localizes in the vicinity of
CC       cell surface receptors in the plasma membrane after receptor
CC       stimulation. Translocates into the nucleus and enhances IFN-gamma
CC       gene transcription in T-cells.
CC   -!- TISSUE SPECIFICITY: Expressed in T-cells and some myeloid cell
CC       lines. Expressed in Th1/Th0 cells with IFN-gamma-producing
CC       potential. {ECO:0000269|PubMed:10523612,
CC       ECO:0000269|PubMed:7951233}.
CC   -!- PTM: Phosphorylated at Tyr-420 by FYN. Autophosphorylation at Tyr-
CC       91 is critical for the activation of TXK, leading to the up-
CC       regulation of IFN-gamma gene transcription.
CC       {ECO:0000269|PubMed:12081135}.
CC   -!- PTM: The cysteine string at the N-terminus is palmitoylated and
CC       required for the proper subcellular location. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. TEC subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- CAUTION: Unlike the other TEC subfamily members, TXK is activated
CC       independently of the activity of phosphatidylinositol 3-kinase,
CC       consistent with its lack of a PH domain. Membrane association is
CC       performed through palmitoylation at the N-terminus. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L27071; AAA74557.1; -; mRNA.
DR   EMBL; U34379; AAB60412.1; -; Genomic_DNA.
DR   EMBL; U34367; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34368; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34369; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34370; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34371; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34372; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34373; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34374; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34375; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34376; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34377; AAB60412.1; JOINED; Genomic_DNA.
DR   EMBL; U34378; AAB60412.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS3480.1; -.
DR   PIR; I84483; I84483.
DR   RefSeq; NP_003319.2; NM_003328.2.
DR   UniGene; Hs.479669; -.
DR   PDB; 2DM0; NMR; -; A=140-251.
DR   PDBsum; 2DM0; -.
DR   ProteinModelPortal; P42681; -.
DR   SMR; P42681; -.
DR   BioGrid; 113145; 4.
DR   IntAct; P42681; 19.
DR   MINT; MINT-1493369; -.
DR   STRING; 9606.ENSP00000264316; -.
DR   BindingDB; P42681; -.
DR   ChEMBL; CHEMBL4367; -.
DR   GuidetoPHARMACOLOGY; 2268; -.
DR   iPTMnet; P42681; -.
DR   PhosphoSitePlus; P42681; -.
DR   BioMuta; TXK; -.
DR   DMDM; 116242835; -.
DR   PaxDb; P42681; -.
DR   PeptideAtlas; P42681; -.
DR   PRIDE; P42681; -.
DR   DNASU; 7294; -.
DR   Ensembl; ENST00000264316; ENSP00000264316; ENSG00000074966.
DR   GeneID; 7294; -.
DR   KEGG; hsa:7294; -.
DR   UCSC; uc003gxx.4; human.
DR   CTD; 7294; -.
DR   DisGeNET; 7294; -.
DR   GeneCards; TXK; -.
DR   H-InvDB; HIX0031512; -.
DR   HGNC; HGNC:12434; TXK.
DR   HPA; HPA062482; -.
DR   MIM; 600058; gene.
DR   neXtProt; NX_P42681; -.
DR   OpenTargets; ENSG00000074966; -.
DR   PharmGKB; PA37090; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000119011; -.
DR   HOGENOM; HOG000233859; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; P42681; -.
DR   KO; K08016; -.
DR   OMA; PIKWSPP; -.
DR   OrthoDB; EOG091G0D46; -.
DR   PhylomeDB; P42681; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   SignaLink; P42681; -.
DR   SIGNOR; P42681; -.
DR   ChiTaRS; TXK; human.
DR   EvolutionaryTrace; P42681; -.
DR   GeneWiki; TXK_(gene); -.
DR   GenomeRNAi; 7294; -.
DR   PRO; PR:P42681; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000074966; -.
DR   CleanEx; HS_TXK; -.
DR   ExpressionAtlas; P42681; baseline and differential.
DR   Genevisible; P42681; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0001012; F:RNA polymerase II regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:NTNU_SB.
DR   GO; GO:0007202; P:activation of phospholipase C activity; ISS:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0001816; P:cytokine production; ISS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; IDA:UniProtKB.
DR   GO; GO:0060335; P:positive regulation of interferon-gamma-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:NTNU_SB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0010543; P:regulation of platelet activation; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0042246; P:tissue regeneration; IBA:GO_Central.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; ATP-binding; Cell membrane;
KW   Complete proteome; Cytoplasm; DNA-binding; Immunity; Kinase;
KW   Lipoprotein; Membrane; Nucleotide-binding; Nucleus; Palmitate;
KW   Phosphoprotein; Polymorphism; Reference proteome; SH2 domain;
KW   SH3 domain; Transcription; Transcription regulation; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN         1    527       Tyrosine-protein kinase TXK.
FT                                /FTId=PRO_0000088175.
FT   DOMAIN       82    142       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      150    246       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      271    527       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     277    285       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF        68     73       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS     14     19       Poly-Cys.
FT   ACT_SITE    390    390       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     299    299       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      91     91       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:12081135}.
FT   MOD_RES     420    420       Phosphotyrosine; by FYN and
FT                                autocatalysis.
FT                                {ECO:0000269|PubMed:12081135}.
FT   VARIANT      45     45       R -> H (in dbSNP:rs7658300).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:7951233}.
FT                                /FTId=VAR_028368.
FT   VARIANT      63     63       R -> C (in dbSNP:rs41265727).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041869.
FT   VARIANT     336    336       R -> Q (in dbSNP:rs11724347).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_028369.
FT   MUTAGEN      91     91       Y->A: Reduces expression levels if IFN-
FT                                gamma. {ECO:0000269|PubMed:12081135}.
FT   MUTAGEN     299    299       K->A: Impairs kinase activity.
FT                                {ECO:0000269|PubMed:9813138}.
FT   STRAND      148    151       {ECO:0000244|PDB:2DM0}.
FT   HELIX       157    167       {ECO:0000244|PDB:2DM0}.
FT   STRAND      175    178       {ECO:0000244|PDB:2DM0}.
FT   STRAND      181    189       {ECO:0000244|PDB:2DM0}.
FT   STRAND      193    197       {ECO:0000244|PDB:2DM0}.
FT   STRAND      200    207       {ECO:0000244|PDB:2DM0}.
FT   STRAND      213    218       {ECO:0000244|PDB:2DM0}.
FT   HELIX       224    231       {ECO:0000244|PDB:2DM0}.
FT   STRAND      237    239       {ECO:0000244|PDB:2DM0}.
SQ   SEQUENCE   527 AA;  61258 MW;  BCCA081F4155CAA6 CRC64;
     MILSSYNTIQ SVFCCCCCCS VQKRQMRTQI SLSTDEELPE KYTQRRRPWL SQLSNKKQSN
     TGRVQPSKRK PLPPLPPSEV AEEKIQVKAL YDFLPREPCN LALRRAEEYL ILEKYNPHWW
     KARDRLGNEG LIPSNYVTEN KITNLEIYEW YHRNITRNQA EHLLRQESKE GAFIVRDSRH
     LGSYTISVFM GARRSTEAAI KHYQIKKNDS GQWYVAERHA FQSIPELIWY HQHNAAGLMT
     RLRYPVGLMG SCLPATAGFS YEKWEIDPSE LAFIKEIGSG QFGVVHLGEW RSHIQVAIKA
     INEGSMSEED FIEEAKVMMK LSHSKLVQLY GVCIQRKPLY IVTEFMENGC LLNYLRENKG
     KLRKEMLLSV CQDICEGMEY LERNGYIHRD LAARNCLVSS TCIVKISDFG MTRYVLDDEY
     VSSFGAKFPI KWSPPEVFLF NKYSSKSDVW SFGVLMWEVF TEGKMPFENK SNLQVVEAIS
     EGFRLYRPHL APMSIYEVMY SCWHEKPEGR PTFAELLRAV TEIAETW
//
